GLYC Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Also see: GLYC Market Cap History GLYC YTD Return |
GLYC Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Also see: GLYC Market Cap History GLYC YTD Return |
GLYC Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
+14.41% CAGR Mouse over chart for data details
|
GLYC Stock Price Chart |
About GlycoMimetics Inc |
GlycoMimetics is a clinical-stage biotechnology company focused on improving the lives of people living with cancer and inflammatory diseases by utilizing the inhibition of carbohydrate interactions that occur on the surface of cells. Co. is developing uproleselan, a specific E-selectin inhibitor, to be used in combination with chemotherapy to treat patients with acute myeloid leukemia, a hematologic cancer, and potentially other hematologic cancers. Co. has designed an antagonist of E-selectin, GMI-1687, that could be suitable for subcutaneous administration. Co. has also selected a primary galectin drug candidate, GMI-2093, for evaluation in preclinical studies. We show 42 historical shares outstanding datapoints in our coverage of GLYC's shares outstanding history. Understanding the changing numbers of GLYC shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like GLYC versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching GLYC by allowing them to research GLYC shares outstanding history as well as any other stock in our coverage universe. |
GLYC Current Stock Quote |
Free GLYC Email Alerts: Get Dividend Alerts Get SEC Filing Alerts |
Video: Shares Outstanding Importance | |
|
GLYC Share Performance |
Shares Outstanding Peers |
GlycoMimetics (GLYC) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
GMED Shares Outstanding History |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.